Cspc Pharmaceutical | 1093 - Ebitda

Aktienkurs
8.81
Täglich Wechseln
-0.17 -1.89%
Monatlich
-5.06%
Jährlich
45.86%
Q2 Prognose
8.80




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Moderna USD -790M 582M 2025-12
Organon & Co USD 383M 135M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Sh Fosun Pharma CNY 1.69B 17.13M 2025-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1B 151.5M 2025-12
WuXi AppTec CNY 5.71B 1.36B 2025-06
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06